Author

Sylke Haal

URSODEOXYCHOLIC ACID FOR THE PREVENTION OF SYMPTOMATIC GALLSTONE DISEASE AFTER BARIATRIC SURGERY: A MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED SUPERIORITY TRIAL
URSODEOXYCHOLIC ACID FOR THE PREVENTION OF SYMPTOMATIC GALLSTONE DISEASE AFTER BARIATRIC SURGERY: A MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED SUPERIORITY TRIAL

Sylke Haal  et al.

URSODEOXYCHOLIC ACID FOR THE PREVENTION OF SYMPTOMATIC GALLSTONE DISEASE AFTER BARIATRIC SURGERY: A MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED SUPERIORITY TRIAL
URSODEOXYCHOLIC ACID FOR THE PREVENTION OF SYMPTOMATIC GALLSTONE DISEASE AFTER BARIATRIC SURGERY: A MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED SUPERIORITY TRIAL

Item 1 - 2 / 2
1